Agouti-related protein is a mediator of diabetic hyperphagia

Regulatory Peptides

Volumn 98, Issue 1-2, 2001, Pages 69-75

  Qu, Song Yi ^a   Yang, Ying Kui ^a   Li, Ji Yao ^a   Zeng, Qun ^a   Gantz, Ira ^a  

^a LANZHOU MEDICAL COLLEGE   (China)

Author keywords

Hypothalamus; Insulin; Neuropeptide Y; Orthovanadate; Streptozotocin

Indexed keywords

AGOUTI RELATED PROTEIN; INSULIN; LEPTIN; MESSENGER RNA; NEUROPEPTIDE Y; STREPTOZOCIN; VANADATE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPERPHAGIA; HYPOTHALAMUS; INSULIN BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; TISSUE LEVEL;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DRINKING; EATING; ENZYME INHIBITORS; HYPERPHAGIA; HYPOTHALAMUS; INSULIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; MALE; NEUROPEPTIDE Y; PROTEIN-TYROSINE-PHOSPHATASE; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; VANADATES;

AGOUTI;

EID: 0035795232     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(00)00230-5     Document Type: Article

References (34)

1. Insulin deficiency is a specific stimulus to hypothalamic neuropeptide Y: A comparison of the effects of insulin replacement and food restriction in streptozocin-diabetic rats
2. Effects of streptozotocin-induced diabetes mellitus and insulin treatment on neuropeptide Y mRNA in the rat hypothalamus
3. Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression
4. Insulin, but not glucose lowering corrects the hyperglucagonemia and increased proglucagon messenger ribonucleic acid levels observed in insulinopenic diabetes
5. Low plasma leptin levels contribute to diabetic hyperphagia in rats
6. STZ-induced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats
7. Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats
8. Central nervous system control of food intake
9. Brain glucose sensing and body energy homeostasis: Role in obesity and diabetes
10. Fasting regulates hypothalamic neuropeptide Y, agouti-related peptide, and pro-opiomelanocortin in diabetic mice independent of changes in leptin or insulin
11. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice
12. ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors
13. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein
14. Changes in hypothalamic agouti-related protein (AGRP), but not α-MSH or pro-opiomelanocortin concentrations in dietary-obese and food-restricted rats
15. Hypothalamic localization of the feeding effect of agouti-related peptide and α-melanocyte-stimulating hormone
16. Coexpression of AGRP and NPY in fasting-activated hypothalamic neurons
17. Characterization of agouti-related protein binding to melanocortin receptors
18. Brainstem application of melanocortin receptor ligands produces long-lasting effects on feeding and body weight
19. Physiological and anatomical circuitry between agouti-related protein and leptin signaling
20. Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting
21. Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor in leptin action
22. Agouti-related protein-like immunoreactivitiy: Characterization of release from hypothalamic tissue and presence in serum
23. Localization of insulin receptor mRNA in rat brain by in situ hybridization
24. Insulin receptors in the central nervous system: Localization, signalling mechanisms and functional aspects
25. Central insulin administration reduces neuropeptide Y mRNA expression in the arcuate nucleus of food-reprived lean (Fa/Fa) but not obese (fa/fa) zucker rats
26. Inhibition of hypothalamic neuropeptide Y gene expression by insulin
27. Insulin and insulin-like growth factor II suppress neuropeptide Y release from the nerve terminals in the paraventricular nucleus: A putative hypothalamic site for energy homeostasis
28. Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozotocin-induced diabetic rats
29. Evidence that hypothalamic neuropeptide Y gene expression and NPY levels in the paraventricular nucleus increase before the onset of hyperphagia in experimental diabetes
30. In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus
31. Insulin-mimetic effects of vanadate, possible implications for future treatment of diabetes
32. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene
33. Protein tyrosine phosphatase-1B in diabetes
34. Human leptin: From an adipocyte hormone to an endocrine mediator